Intervention 1: Intervention group: Boswellia Resin extract receiving group, 3 times/day (400 mg). Intervention 2: Control group: Placebo group, 3 times/day (400 mg).

2 trials

Sponsors

Shahid Beheshti University of Medical Sciences

Conditions

Alzheimer's disease. Alzheimer's diseaseParkinson disease. Parkinson disease

Phase 3

The effect of Boswellia resin extract on treatment of patients with Parkinson's disease

Active, not recruitingIRCT20170315033086N4

Shahid Beheshti University of Medical SciencesParkinson disease. Parkinson disease

Start: 2017-06-22Target: 50Updated: 2019-04-23

Unknown Phase

The Investigation on the Effect of Boswellia resin Extract on Plasma Levels of inflammatory factors in Patients with Alzheimer’s disease

Active, not recruitingIRCT20170315033086N3

Shahid Beheshti University of Medical SciencesAlzheimer's disease. Alzheimer's disease

Start: 2017-05-23Target: 50Updated: 2019-04-23